Levothyroxine Sodium
- Product NDC
- 68788-8793
- 11-digit product format
- 687888793
- Labeler code
- 68788
- Product ID
- 68788-8793_a0ffe111-3574-4481-a732-b68a7d58ef71
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Levothyroxine Sodium
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Preferred Pharmaceuticals Inc.
- Application
- ANDA209713
- Marketing category
- ANDA
- Marketing start
- 2024-12-17
- Substance
- LEVOTHYROXINE SODIUM
- Active strength
- .175 mg/1
- Pharmacologic classes
- Thyroxine [CS], l-Thyroxine [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Levothyroxine Sodium
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| LEVOTHYROXINE SODIUM | .175 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 9J765S329G |
| Rxcui | 966249 |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 68788-8793-3 | 68788879303 | 30 TABLET in 1 BOTTLE (68788-8793-3) | 30 tablet | 2024-12-17 | No | No | Historical |
| 68788-8793-9 | 68788879309 | 90 TABLET in 1 BOTTLE (68788-8793-9) | 90 tablet | 2024-12-17 | No | No | Historical |